
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The Company is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Our development pipeline consists of multiple programs and clinical indications at various stages of dev... The Company is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Our development pipeline consists of multiple programs and clinical indications at various stages of development. Our portfolio currently consists of two product candidates: EOM613 and EOM147. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0539 | 64.3198090692 | 0.0838 | 0.1377 | 0.0838 | 3842 | 0.1377 | CS |
4 | -0.0165 | -10.7003891051 | 0.1542 | 0.1542 | 0.0837 | 1005 | 0.14112482 | CS |
12 | 0.0162 | 13.3333333333 | 0.1215 | 0.16 | 0.0123 | 8879 | 0.15416416 | CS |
26 | 0.0587 | 74.3037974684 | 0.079 | 0.205 | 0.0123 | 5769 | 0.15821162 | CS |
52 | -0.0198 | -12.5714285714 | 0.1575 | 0.248 | 0.0123 | 4120 | 0.1557236 | CS |
156 | -0.0968 | -41.2793176972 | 0.2345 | 0.94 | 0.0123 | 4454 | 0.34428945 | CS |
260 | 0.1108 | 411.895910781 | 0.0269 | 0.98 | 0.0123 | 15672 | 0.22177966 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions